DNTH EBITDA Margin
Dianthus Therapeutics Inc · EBITDA Margin
DNTH EBITDA Margin
Latest reported-6584.49%period ending
DNTH Quarterly EBITDA Margin (0.00% → -6584.49%)
Quarterly ebitda margin
High-resolution chart · PNG
DNTH ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -6,584.4941% | |
| -8,803.0238% | |
| 34,507.7465% | |
| -9,259.0909% | |
| -16,336.7876% | |
| -2,526.0533% | |
| -2,138.914% | |
| -1,153.6832% | |
| -939.1304% | |
| -1,560.7551% | |
| -2,288.8403% | |
| -1,595.671% | |
| -1,338.9061% | |
| -1,472.2689% | |
| -856.766% | |
| -560.3581% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |